Centessa Pharmaceuticals Plc ADR
(CNTA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -81,862 | -38,046 | -151,085 | -114,248 | -75,600 |
| Depreciation Amortization | 476 | 240 | 810 | 564 | 326 |
| Income taxes - deferred | 1,001 | 434 | -26,529 | -26,380 | -23,490 |
| Accounts payable and accrued liabilities | -6,434 | -4,250 | -2,722 | -3,308 | -3,391 |
| Other Working Capital | -15,046 | -9,168 | -18,830 | -15,390 | -11,039 |
| Other Operating Activity | 23,999 | 13,504 | 38,014 | 29,470 | 21,294 |
| Operating Cash Flow | $-77,866 | $-37,286 | $-160,342 | $-129,292 | $-91,900 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -38,697 | 16,762 | -126,835 | -108,588 | -157,337 |
| PPE Investments | N/A | N/A | -169 | -141 | -98 |
| Investing Cash Flow | $-38,697 | $16,762 | $-127,004 | $-108,729 | $-157,435 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 118,567 | 10,493 | 21,117 | 14,756 | 12 |
| Other Financing Activity | -2,761 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $115,806 | $10,493 | $21,117 | $14,756 | $12 |
| Exchange Rate Effect | 99 | 219 | 615 | 1,119 | 899 |
| Beginning Cash Position | 128,030 | 128,030 | 393,644 | 393,644 | 393,644 |
| End Cash Position | 127,372 | 118,218 | 128,030 | 171,498 | 145,220 |
| Net Cash Flow | $-658 | $-9,812 | $-265,614 | $-222,146 | $-248,424 |
| Free Cash Flow | |||||
| Operating Cash Flow | -77,866 | -37,286 | -160,342 | -129,292 | -91,900 |
| Capital Expenditure | N/A | N/A | -169 | -141 | -98 |
| Free Cash Flow | -77,866 | -37,286 | -160,511 | -129,433 | -91,998 |